Nodisen (Diphenhydramine Hydrochloride)

Diphenhydramine Hydrochloride, the active ingredient in Nodisen, is a first‑generation H1 antihistamine presented as an oral tablet for oral use and available over the counter in the European market. It provides symptomatic relief for allergic rhinitis, urticaria, common cold manifestations such as runny nose and sneezing, and short‑term insomnia, and is used in both adult and pediatric populations when appropriate.

GNH USA supplies Nodisen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory conformity across global markets.

Diphenhydramine is a first‑generation H1 antihistamine that alleviates symptoms across several allergic and related conditions.

Allergic rhinitis: reduces nasal congestion, itching, sneezing, and watery discharge, improving breathing comfort. Urticaria: alleviates skin itching, redness, and hives, helping restore normal skin appearance. Common cold symptoms: eases runny nose, sneezing, and watery eyes, providing symptomatic relief during viral upper respiratory infections. Short‑term insomnia: induces drowsiness to facilitate sleep onset for occasional sleeplessness, without long‑term dependence.

Diphenhydramine may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Drowsiness: feeling of sleepiness or reduced alertness. - Dry mouth: decreased salivation leading to thirst. - Blurred vision: temporary difficulty focusing. - Constipation: slowed gastrointestinal motility. - Dizziness: light‑headed sensation, especially when standing.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with swelling, difficulty breathing. - Cardiac arrhythmia: irregular heart rhythm, potentially dangerous. - Seizures: convulsive episodes, particularly in overdose. - Hallucinations or confusion: altered mental status. - High fever: unexplained elevated body temperature.

Before using Nodisen, consider the following precautions to ensure safe and effective use.

- Avoid driving or operating machinery: due to possible sedation and impaired coordination. - Use with caution in elderly patients: increased anticholinergic sensitivity may raise risk of confusion and falls. - Do not combine with alcohol or other CNS depressants: risk of excessive drowsiness and respiratory depression. - Consult a healthcare professional if pregnant or breastfeeding: safety data are limited and risks must be weighed. - Review all concurrent medications for potential interactions: especially other antihistamines, MAO inhibitors, and sedatives. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Diphenhydramine can interact with several medicines; awareness of major and moderate interactions helps prevent adverse effects.

Major Interactions (Avoid): - Alcohol and central nervous system depressants: may cause profound sedation and respiratory depression. - Monoamine oxidase inhibitors (MAOIs): can increase anticholinergic toxicity and hypertensive reactions. - Other antihistamines: additive sedation and anticholinergic burden. - Tricyclic antidepressants: heightened anticholinergic side effects and cardiac effects.

Moderate Interactions (Monitor Closely): - Anticholinergic drugs (e.g., atropine, ipratropium): may intensify dry mouth, urinary retention, and constipation. - Sedative agents (e.g., benzodiazepines, opioids): require dose adjustment due to enhanced drowsiness. - CYP450 inhibitors (e.g., cimetidine, erythromycin): can increase diphenhydramine plasma levels.